Pharmacotherapy of multiple myeloma: an economic perspective

Author： Messori Andrea   Trippoli Sabrina   Santarlasci Benedetta  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.4, 2003-04, pp. : 515-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of multiple myeloma

By Hussein Mohamad A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 767-781

Informa Healthcare

Access to resources Recommend Favorite

Multiple myeloma

By Samson Diana   Singer Charles  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 365-370

Royal College Of Physicians

Access to resources Recommend Favorite

First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dellAdulto) Multiple Myeloma Working Party Perspective

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 906-922

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma: An Overview of Clinical and Economic Information

By Messori Andrea  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 269-285

Adis International

Access to resources Recommend Favorite

Bortezomib in multiple myeloma

By Terpos Evangelos   Roussou Maria   Dimopoulos Meletios-Athanassios  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 639-654

Informa Healthcare

Access to resources Recommend Favorite